Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea · Delayed Price · Currency is KRW 11,140
-290 (-2.54%)
Sep 18, 2025, 2:40 PM KST
Chabiotech Market Cap
Chabiotech has a market cap or net worth of 868.18 billion as of September 17, 2025. Its market cap has decreased by -9.31% in one year.
Market Cap
868.18B
Enterprise Value
1.73T
Revenue
1.15T
Ranking
n/a
PE Ratio
n/a
Stock Price
11,140.00
Market Cap Chart
Since February 23, 2009, Chabiotech's market cap has increased from 334.13B to 868.18B, an increase of 159.83%. That is a compound annual growth rate of 5.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 868.18B | 35.34% |
| Dec 30, 2024 | 641.46B | -41.85% |
| Dec 28, 2023 | 1,103.20B | 50.82% |
| Dec 29, 2022 | 731.49B | -34.83% |
| Dec 30, 2021 | 1,122.40B | 6.53% |
| Dec 30, 2020 | 1,053.61B | 39.68% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.74T |
| Celltrion | 37.16T |
| ALTEOGEN | 26.35T |
| Yuhan | 8,924.87B |
| SK Biopharmaceuticals | 8,669.28B |
| Peptron | 6,977.56B |
| PharmaResearch | 6,524.70B |
| ABL Bio | 5,528.46B |